Nova Eye Medical Dividends and Buybacks

Dividend criteria checks 0/6

Nova Eye Medical does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-23.2%

Buyback Yield

Total Shareholder Yield-23.2%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

Nova Eye Medical Limited (ASX:EYE) Stock Rockets 29% But Many Are Still Ignoring The Company

Jan 11
Nova Eye Medical Limited (ASX:EYE) Stock Rockets 29% But Many Are Still Ignoring The Company

We Think Nova Eye Medical (ASX:EYE) Can Afford To Drive Business Growth

Nov 04
We Think Nova Eye Medical (ASX:EYE) Can Afford To Drive Business Growth

Nova Eye Medical Limited (ASX:EYE) Might Not Be As Mispriced As It Looks After Plunging 26%

Sep 22
Nova Eye Medical Limited (ASX:EYE) Might Not Be As Mispriced As It Looks After Plunging 26%

Take Care Before Diving Into The Deep End On Nova Eye Medical Limited (ASX:EYE)

Aug 06
Take Care Before Diving Into The Deep End On Nova Eye Medical Limited (ASX:EYE)

Nova Eye Medical Limited (ASX:EYE) Soars 29% But It's A Story Of Risk Vs Reward

Apr 18
Nova Eye Medical Limited (ASX:EYE) Soars 29% But It's A Story Of Risk Vs Reward

Is There An Opportunity With Nova Eye Medical Limited's (ASX:EYE) 43% Undervaluation?

Mar 26
Is There An Opportunity With Nova Eye Medical Limited's (ASX:EYE) 43% Undervaluation?

News Flash: Analysts Just Made A Captivating Upgrade To Their Nova Eye Medical Limited (ASX:EYE) Forecasts

Jan 19
News Flash: Analysts Just Made A Captivating Upgrade To Their Nova Eye Medical Limited (ASX:EYE) Forecasts

Further Upside For Nova Eye Medical Limited (ASX:EYE) Shares Could Introduce Price Risks After 38% Bounce

Dec 27
Further Upside For Nova Eye Medical Limited (ASX:EYE) Shares Could Introduce Price Risks After 38% Bounce

We're Not Very Worried About Nova Eye Medical's (ASX:EYE) Cash Burn Rate

Sep 03
We're Not Very Worried About Nova Eye Medical's (ASX:EYE) Cash Burn Rate

Improved Revenues Required Before Nova Eye Medical Limited (ASX:EYE) Stock's 43% Jump Looks Justified

Apr 17
Improved Revenues Required Before Nova Eye Medical Limited (ASX:EYE) Stock's 43% Jump Looks Justified

Is Nova Eye Medical (ASX:EYE) In A Good Position To Invest In Growth?

Dec 16
Is Nova Eye Medical (ASX:EYE) In A Good Position To Invest In Growth?

We Think Nova Eye Medical (ASX:EYE) Needs To Drive Business Growth Carefully

Aug 27
We Think Nova Eye Medical (ASX:EYE) Needs To Drive Business Growth Carefully

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if EYE's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if EYE's dividend payments have been increasing.


Dividend Yield vs Market

Nova Eye Medical Dividend Yield vs Market
How does EYE dividend yield compare to the market?
SegmentDividend Yield
Company (EYE)n/a
Market Bottom 25% (AU)2.6%
Market Top 25% (AU)6.1%
Industry Average (Medical Equipment)1.6%
Analyst forecast (EYE) (up to 3 years)n/a

Notable Dividend: Unable to evaluate EYE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate EYE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate EYE's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as EYE has not reported any payouts.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/07 18:48
End of Day Share Price 2025/02/07 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Nova Eye Medical Limited is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tanushree JainBell Potter
Michael YouldenMST Financial Services Pty Limited
Robin MorganTaylor Collison Limited